According to the company's statement on the Saudi Stock Exchange (Tadawul) website, this is due to the following reasons:
- Gross Profit: The company recorded an increase in gross profit of 7.6 million riyals, reaching 149.7 million riyals in 2025 compared to 142.1 million riyals in 2024. This is due to the company’s direction towards continuous and permanent investment to support sales growth.
- Operating expenses: Operating expenses increased by 4.6 million riyals compared to the previous year, due to the company supporting its investments, including new openings throughout the Kingdom.
There is also an increase in financing benefits of 1.2 million riyals compared to the previous year, mainly including interest expense related to lease contract obligations and bank facility interest, in order to support the growth in sales.
The Board of Directors of “Al-Mujtama’ Medical” recommended distributing cash dividends to shareholders for the fiscal year 2025.
The company said that the total amount distributed is estimated at 2.375 million riyals, while the share per share of the distribution is 0.25 riyals.
The entitlement to cash distributions will be for shareholders who own shares in the company at the end of the day of the company’s general assembly meeting (which will be announced later), and who are registered in the company’s shareholder register with the Securities Depository Center Company (Edaa) at the end of the second trading day following the entitlement date.
She noted that the distribution date would be determined later in accordance with the relevant regulatory controls and procedures.
